“Consumer Concerns Over Heart Health Drive Grocery Choices Amid FDA’s Soy Protein Claim Controversy”
According to the Hartman Group, heart health is the primary concern for consumers when shopping for groceries. The research reveals that 55% of U.S. shoppers aim to limit or eliminate saturated fat from their diets, while nearly 40% seek to incorporate healthier fats, such as polyunsaturated and monounsaturated fats, in place of saturated fats. Reactions from manufacturers and industry organizations have been varied regarding the FDA’s proposal to eliminate the soy protein health claim. The Soyfoods Association of North America (SANA) expressed concern on Monday, advocating for the retention of the current claim, which states: “25 grams of soy protein a day, as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease.”
SANA’s statement emphasized that numerous scientific studies, both before and after the approval of the soy protein health claim in 1999, consistently demonstrate that soy protein can reduce LDL cholesterol levels, reinforcing the need for continued support of the unqualified claim. They pointed out that the FDA’s decision contradicts the positions of 12 other countries that have authorized health claims regarding soy protein and heart disease, including Health Canada’s recent approval in 2015.
The Natural Products Association also raised questions about the FDA’s actions. CEO Daniel Fabricant deemed the FDA’s decision “somewhat unexpected,” noting the lack of explanation for the agency’s sudden action. With his previous experience as head of the FDA’s Division of Dietary Supplement Programs, he is likely well-acquainted with the workings of federal regulatory agencies. Meanwhile, the American Heart Association has supported the revocation of the soy protein claim, questioning any direct health benefits. According to Reuters, they highlighted that during the FDA’s evidence reevaluation in 2008, the association noted, “The direct cardiovascular health benefit of soy protein or isoflavone supplements is minimal at best.”
Should the FDA proceed with revoking the unqualified health claim on soy protein products, predicting consumer reactions and potential impacts on their purchasing behavior remains challenging. The American Heart Association has expressed opposition to the FDA adopting qualified language for affected products, stating that research indicates consumers often misunderstand qualified health claims, which are based on limited and inconsistent evidence.
Once the proposed rule to revoke the soybean protein health claim is initiated, it is unlikely that the FDA will change its course unless a significant number of comments object to the move. Potential comments may come from companies like DuPont, which produces isolated soy protein, and Gardein, known for its soy-based protein products. Furthermore, it’s improbable that the agency will reevaluate its 11 other approved health claims related to food products unless substantial pressure is applied. Only one of these claims pertains to soybean protein, which is currently under review for possible revocation. However, it is noteworthy that the FDA recently approved labeling soybean oil as heart-healthy, citing its potential to reduce the risk of coronary heart disease and lower LDL cholesterol.
In another context, consumers may also wonder if calcium citrate causes gas, as digestive reactions can vary. Understanding the implications of both soy protein and calcium citrate on health can help consumers make informed dietary choices.
